What are the signs, symptoms, diagnosis, evaluation, treatments, and complications of Subarachnoid Hemorrhage (SAH)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Subarachnoid Hemorrhage: Signs, Symptoms, Diagnosis, Evaluation, Treatment, and Complications

Signs and Symptoms

The hallmark presentation of subarachnoid hemorrhage (SAH) is a sudden-onset, severe headache described as "the worst headache of my life" by approximately 80% of patients who can provide a history. 1, 2

  • Thunderclap headache (instantly peaking pain) is the classic presentation, with headache reaching maximal intensity immediately 1
  • A warning or sentinel headache may precede the major SAH in 10-43% of patients, often occurring 2-8 weeks before overt rupture 1
  • Nausea and/or vomiting occurs in approximately 77% of patients 1
  • Loss of consciousness is reported in about 53% of patients 1
  • Nuchal rigidity (stiff neck) is present in approximately 35% of patients 1
  • Photophobia is a common associated symptom 1
  • Focal neurological deficits, including cranial nerve palsies, may be present 1
  • Seizures occur in up to 20% of patients, most commonly in the first 24 hours 1, 3

Diagnosis and Evaluation

Initial Assessment

  • The Ottawa SAH Rule should be applied to identify patients at high risk for SAH 1
    • Age ≥40 years
    • Neck pain or stiffness
    • Witnessed loss of consciousness
    • Onset during exertion
    • Thunderclap headache
    • Limited neck flexion on examination

Diagnostic Algorithm

  1. Non-contrast head CT is the cornerstone of SAH diagnosis 1, 3

    • Sensitivity approaches 100% within first 3 days, decreasing to 93% at 24 hours and 57-85% by day 6 3
    • Should be performed on a high-quality scanner and interpreted by a board-certified neuroradiologist 1
  2. If CT is negative but clinical suspicion remains high:

    • For patients presenting >6 hours from symptom onset: lumbar puncture (LP) for xanthochromia evaluation is necessary 1, 3
    • Spectrophotometric analysis of CSF for xanthochromia has a sensitivity of 100% and specificity of 95.2% 1
  3. For confirmed SAH:

    • Digital subtraction angiography (DSA) is indicated to diagnose/exclude cerebral aneurysm(s) 1
    • DSA helps determine the optimal strategy for aneurysm intervention 1

Treatment

Initial Management

  • Immediate transfer to a high-volume center (>35 SAH cases/year) with multidisciplinary neurointensive care services 3
  • Blood pressure control is essential to reduce rebleeding risk while maintaining cerebral perfusion 2, 3
    • Systolic blood pressure should be maintained below 160 mmHg using titratable agents like nicardipine, labetalol, or clevidipine 2

Medical Management

  • Nimodipine 60 mg every 4 hours for 21 consecutive days is recommended for all SAH patients to improve neurological outcomes by reducing the incidence and severity of delayed cerebral ischemia 3, 4
  • Acetaminophen should be administered to all patients with SAH-associated headache as the foundation of pain management 2
  • Maintenance of euvolemia rather than hypervolemia is recommended to prevent delayed cerebral ischemia (DCI) 3, 5
  • Seizure prophylaxis should be considered, especially in the first 24 hours 3, 5
  • Acute symptomatic hydrocephalus should be managed by cerebrospinal fluid diversion via external ventricular drainage or lumbar drainage 3

Definitive Treatment

  • Early securing of the ruptured aneurysm (within 24-72 hours) is recommended to prevent rebleeding 3, 5
  • For aneurysms amenable to both techniques, endovascular coiling is generally preferred over surgical clipping, especially for posterior circulation aneurysms 3
  • Complete obliteration of the aneurysm should be the goal whenever possible 3

Complications and Their Management

Rebleeding

  • Risk is highest within the first 24-72 hours 5
  • Prevention through early aneurysm securing and blood pressure control 3, 5

Delayed Cerebral Ischemia (DCI)

  • Occurs in up to 30% of SAH patients who survive the initial hemorrhage 6
  • Prevention with nimodipine administration is the cornerstone of management 3, 6
  • For symptomatic DCI, induced hypertension is recommended unless contraindicated 3, 6

Hydrocephalus

  • Can occur acutely or develop over days to months following SAH 5
  • Treated with external ventricular drainage (acute) or permanent CSF diversion (chronic) 3, 5

Seizures

  • Occur in up to 20% of patients, most commonly in first 24 hours 1, 3
  • More common in SAH associated with intracerebral hemorrhage, hypertension, and middle cerebral and anterior communicating artery aneurysms 1

Medical Complications

  • Cardiac dysfunction, neurogenic pulmonary edema, electrolyte abnormalities, and infections are common 7
  • Require vigilant monitoring and prompt treatment to prevent secondary brain injury 7

Common Pitfalls and Caveats

  • Misdiagnosis occurs in up to 12% of cases, with the most common error being failure to obtain a non-contrast head CT 1, 3
  • Sentinel headaches are frequently missed, but recognizing them can be lifesaving 1
  • CT sensitivity decreases significantly after 5-7 days, requiring lumbar puncture for diagnosis 1
  • CTA alone is insufficient to rule out SAH as it only evaluates for vascular pathology, not hemorrhage 1
  • Nimodipine can cause hypotension; if administered intravenously by mistake, significant hypotension may require cardiovascular support with pressor agents 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Headache in Subarachnoid Hemorrhage

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Subarachnoid and Subdural Hemorrhage

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Critical care of patients with subarachnoid hemorrhage.

Neurosurgery clinics of North America, 1994

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.